Tiansheng Pharmaceutical Group Co Ltd (002872.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100002QC3
Tiansheng Pharmaceutical Group Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 569.71 m CNY | 514.09 m CNY |
| Gross profit | 261.14 m CNY | 252.50 m CNY |
| Operating income | -94.03 m CNY | -38.23 m CNY |
| EBIT | -83.00 m CNY | -50.58 m CNY |
| Net income | -87.40 m CNY | -55.42 m CNY |
| Diluted EPS – continuing operations | -0.27 CNY | -0.17 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in pharmaceutical manufacturing and circulation activities. The company offers pediatric cough granules, erythromycin enteric-coated capsules, yinshen tongluo capsules, yanshen jianwei capsules, and sodium chloride injection products. It provides products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, pediatrics, digestive, gynecological, orthopedic, cardiology, diabetes, anesthetic, oncology, hepatobiliary, hematological, surgical, and others. In addition, it provides traditional Chinese medicines and glucose injection. Tiansheng Pharmaceutical Group Co., Ltd. was founded in 2001 and is headquartered in Chongqing, China.
More stocks
- LESAKA TECHNOLOGIES INC (LSAK)
- Shandong Sinoglory Health (603182.SS)
- Bukwang Pharm (003000.KS)
- Chongqing Sifang New Material Co. Ltd. (605122.SS)
- M-tron Industries, Inc. (MPTI)
- Sky Network Television Ltd (SKT.AX)
- Gérard Perrier Industrie S.A. (PERR.PA)
- Dongwoon Anatech Co Ltd (094170.KQ)
- Nongshim Holdi (072710.KS)
- Axgate Co., Ltd. (356680.KQ)
- Dimand S.A. (DIMAND.AT)
- Chien Kuo Construction Co Ltd (5515.TW)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.